Fresenius Medical Care AG & Co. KGaA (FMS) posted a 39% drop in first-quarter 2013 net income attributable to shareholders to $225.5 million, from last year's $370.5 million. Earnings per ordinary share for the period were $0.74, and earnings per ordinary ADS amounted to $0.37, a 39.6% decrease compared with the prior year.
Operating income or EBIT slid 2% to $493 million, from $503 million in the first quarter of 2012.
However, net revenue for the quarter advanced by 6.6% to $3.46 billion, from $3.25 billion a year ago, and organic revenue growth worldwide was 4%.
For 2013, the company confirmed its revenue and earnings outlook. Full-year revenue is estimated to grow to more than $14.6 billion, translating into a growth rate of more than 6%, while net income attributable to shareholders of Fresenius Medical Care is expected to be between $1.1 billion and $1.2 billion.
For comments and feedback: editorial@rttnews.com